| Primary |
| Depression |
63.2% |
| Product Used For Unknown Indication |
15.8% |
| Anxiety |
10.5% |
| Bipolar I Disorder |
5.3% |
| Narcolepsy |
5.3% |
|
| Congestive Cardiomyopathy |
14.3% |
| Intraocular Pressure Increased |
14.3% |
| Shock |
14.3% |
| Acute Respiratory Distress Syndrome |
7.1% |
| Blepharospasm |
7.1% |
| Blood Glucose Decreased |
7.1% |
| Hyperglycaemic Hyperosmolar Nonketotic Syndrome |
7.1% |
| Neuroleptic Malignant Syndrome |
7.1% |
| Skin Laceration |
7.1% |
| Suicide Attempt |
7.1% |
| Ventricular Tachycardia |
7.1% |
|
| Secondary |
| Depression |
45.9% |
| Product Used For Unknown Indication |
22.6% |
| Drug Use For Unknown Indication |
4.4% |
| Hypertension |
3.9% |
| Insomnia |
3.7% |
| Suicide Attempt |
3.4% |
| Panic Disorder |
2.9% |
| Major Depression |
2.4% |
| Hyperlipidaemia |
1.4% |
| Gastric Ulcer |
1.2% |
| Anxiety |
1.0% |
| Diabetes Mellitus |
1.0% |
| Intentional Overdose |
1.0% |
| Irritability |
1.0% |
| Irritable Bowel Syndrome |
1.0% |
| Drug Abuse |
0.7% |
| Neuroleptic Malignant Syndrome |
0.7% |
| Thrombosis Prophylaxis |
0.7% |
| Constipation |
0.5% |
| Hypoaesthesia |
0.5% |
|
| Completed Suicide |
14.0% |
| Renal Failure Acute |
9.3% |
| Neuroleptic Malignant Syndrome |
8.1% |
| Toxicity To Various Agents |
8.1% |
| Pyrexia |
7.0% |
| Congestive Cardiomyopathy |
4.7% |
| Erythema Multiforme |
4.7% |
| Galactorrhoea |
4.7% |
| Hepatic Function Abnormal |
4.7% |
| Rhabdomyolysis |
4.7% |
| Sinus Bradycardia |
4.7% |
| Pulmonary Oedema |
3.5% |
| Somnolence |
3.5% |
| Ventricular Arrhythmia |
3.5% |
| Ventricular Tachycardia |
3.5% |
| Altered State Of Consciousness |
2.3% |
| Circulatory Collapse |
2.3% |
| Death |
2.3% |
| Device Expulsion |
2.3% |
| Drug Eruption |
2.3% |
|
| Concomitant |
| Depression |
37.8% |
| Product Used For Unknown Indication |
15.8% |
| Insomnia |
6.2% |
| Major Depression |
5.0% |
| Constipation |
4.5% |
| Hypertension |
4.2% |
| Pneumonia Aspiration |
2.7% |
| Rheumatoid Arthritis |
2.4% |
| Anxiety |
2.3% |
| Bipolar Disorder |
2.3% |
| Schizophrenia |
2.3% |
| Panic Disorder |
2.1% |
| Pain |
2.0% |
| Infection Prophylaxis |
1.8% |
| Schizophrenia, Undifferentiated Type |
1.8% |
| Dyslipidaemia |
1.5% |
| Extrapyramidal Disorder |
1.5% |
| Diabetes Mellitus |
1.4% |
| Eating Disorder |
1.4% |
| Constipation Prophylaxis |
1.2% |
|
| Liver Disorder |
13.7% |
| Weight Increased |
7.8% |
| Pyrexia |
6.9% |
| Viral Infection |
6.9% |
| Off Label Use |
4.9% |
| Overdose |
4.9% |
| Somnolence |
4.9% |
| Suicidal Ideation |
4.9% |
| Suicide Attempt |
4.9% |
| Vertigo Positional |
4.9% |
| Anaphylactic Shock |
3.9% |
| Azoospermia |
3.9% |
| Dizziness |
3.9% |
| Irritability |
3.9% |
| Loss Of Consciousness |
3.9% |
| White Blood Cell Count Increased |
3.9% |
| Asphyxia |
2.9% |
| Confusional State |
2.9% |
| Delirium |
2.9% |
| Interstitial Lung Disease |
2.9% |
|
| Interacting |
| Cancer Pain |
20.0% |
| Procedural Pain |
20.0% |
| Neuralgia |
17.5% |
| Bipolar Disorder |
15.0% |
| Pain |
12.5% |
| Depression |
10.0% |
| Dysmenorrhoea |
2.5% |
| Product Used For Unknown Indication |
2.5% |
|
| Serotonin Syndrome |
33.3% |
| Death |
16.7% |
| Drug Effect Decreased |
16.7% |
| Suicide Attempt |
16.7% |
| White Blood Cell Count Increased |
16.7% |
|
